VANCOUVER, B.C.—Point-of-care ultrasound of the abdomen substantially reduces the time to treatment change and time to remission in patients with inflammatory bowel disease, according to new research.
Previously published studies have suggested that ultrasound, which can be performed in real time during a clinic visit, has a sensitivity of 86% to 88% and a specificity of 93% to 96% for detecting IBD activity, according to investigator Noa Krugliak Cleveland, MD, an assistant professor of